Zaloguj się

Gotowe bibliografie tematyczne / Anti-Parkinson / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Anti-Parkinson.

Artykuły w czasopismach na temat „Anti-Parkinson”

Autor: Grafiati

Data publikacji: 2 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Anti-Parkinson”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Chalorak, Pawanrat, Prapaporn Jattujan, Saksit Nobsathian, Tanate Poomtong, Prasert Sobhon, and Krai Meemon. "Holothuria scabraextracts exhibit anti-Parkinson potential inC. elegans: A model for anti-Parkinson testing." Nutritional Neuroscience 21, no. 6 (2017): 427–38. http://dx.doi.org/10.1080/1028415x.2017.1299437.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Ingala, Judith. "An anti-parkinson add-on drug." Geriatric Nursing 6, no. 4 (1985): 193. http://dx.doi.org/10.1016/s0197-4572(85)80081-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Austin, Publishing Group. "Hemodiafiltration for Intoxication with Lithium Unmasking Its Anti-Parkinsonian Effect." Journal of Family Medicine 8, no. 1 (2021): 1237. https://doi.org/10.26420/jfammed.2021.1237.

Pełny tekst źródła

Streszczenie:

From lithium it is known that it exhibits an anti-Parkinson effect [1]. Accordingly, smokers develop less frequently Parkinson’s Disease (PD) than the non-smoking population [2]. This is because tobacco contains a significant amount of lithium [3]. The anti-PD effect of lithium is explained by increased autophagy and reduction of intracellular a-synuclein [3]. Lithium inhibits GSK-3<em>ß</em> and consequently increases the <em>ß</em>-catenine activity [4]. Development of a Parkinson crisis due to flushing out of lithium by Hemodiafiltration (HDF), as in the followin

Style APA, Harvard, Vancouver, ISO itp.

4

Kostelnik, Adam, Alexander Cegan, and Miroslav Pohanka. "Anti-Parkinson Drug Biperiden Inhibits Enzyme Acetylcholinesterase." BioMed Research International 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/2532764.

Pełny tekst źródła

Streszczenie:

Biperiden is a drug used in Parkinson disease treatment and it serves also as an antiseizures compound in organophosphates poisoning. It acts as antagonist of muscarinic receptor activated by acetylcholine while the enzyme acetylcholinesterase (AChE) cleaves acetylcholine in synaptic junction into choline and acetic acid. This enzyme is inhibited by various compounds; however there has not been proposed evidence about interaction with biperiden molecule. We investigated this interaction using standard Ellman’s assay and experimental findings were critically completed with an in silico predicti

Style APA, Harvard, Vancouver, ISO itp.

5

Simon, K., V. Harmat, Z. Török, Z. Böcskei, and I. Hermecz. "Isostructural Metabolites of Two Anti-Parkinson Drugs." Acta Crystallographica Section C Crystal Structure Communications 54, no. 6 (1998): 811–13. http://dx.doi.org/10.1107/s0108270197019896.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Gerlach, M., and P. Riederer. "Aktuelle präklinische Befunde zu Anti-Parkinson-Mitteln." Der Nervenarzt 74 (March 1, 2003): s2—s6. http://dx.doi.org/10.1007/s00115-003-1481-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Youdim, Moussa BH. "Rasagiline: an anti-Parkinson drug with neuroprotective activity." Expert Review of Neurotherapeutics 3, no. 6 (2003): 737–49. http://dx.doi.org/10.1586/14737175.3.6.737.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Schiess, Mya. "Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration." Archives of Neurology 60, no. 8 (2003): 1043. http://dx.doi.org/10.1001/archneur.60.8.1043.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

RAZZAGHI-ASL, NIMA, SARA SHAHABIPOUR, AHMAD EBADI, and AZAM BAGHERI. "Quantum chemical analysis of potential anti-Parkinson agents." Journal of Chemical Sciences 127, no. 7 (2015): 1211–20. http://dx.doi.org/10.1007/s12039-015-0889-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Kumar, Rajan, Rakesh Kumar, Abhinav Anand, Neha Sharma, and Navneet Khurana. "PREDICTION OF ANTI-PARKINSON POTENTIAL OF PHYTOCONSTITUENTS USING PREDICTION OF ACTIVITY SPECTRA OF SUBSTANCES SOFTWARE." Asian Journal of Pharmaceutical and Clinical Research 11, no. 14 (2018): 48. http://dx.doi.org/10.22159/ajpcr.2018.v11s2.28578.

Pełny tekst źródła

Streszczenie:

Objective: Neurodegenerative disorders are group of diseased conditions in which there is loss of neuron cells occur. The main objective of this study to find/search out the phytochemical with the help of prediction of activity spectra of substances (PASSs), those show maximum activity over the selected targets of the Parkinson’s disease (PD).Methods: PASSs is a valuable software which is used in this study, to predict the anti-Parkinson activity of different compounds. Canonical simplified molecular-input line-entry system is used for the prediction of anti-Parkinson activity which is obtaine

Style APA, Harvard, Vancouver, ISO itp.

11

Adiba, Afreen1* Shaik Mohd Khasim1 Saniya Begum2 Shahnaz Zainab2 Shaik Shahnaz Begum2 Aman Khan2 Md. Ajaz Kaiser1. "Evaluation Of Anti-Parkinsonian Effect Of Ethanolic Leaf Extract Of Allium, Jacquemontia And Tabernaemontana On Experimental Mice." International Journal in Pharmaceutical Sciences 2, no. 6 (2024): 21–33. https://doi.org/10.5281/zenodo.11409910.

Pełny tekst źródła

Streszczenie:

<strong>Objectives:         </strong> The study aims to evaluate phytochemical screening and assess the anti-parkinsonian effect of polyherbal formulation containing ethanolic extract of Allium fistulosum, Jacquemontia caerulea and Tabernaemontana divaricata (EEAJT) in Haloperidol induced Parkinson’s disease on experimental mice. <strong>Methods:</strong> The anti-Parkinsonian activity of polyherbal formulation (EEAJT) was studied in Haloperidol (1mg/kg i.p.) induced Parkinson animal model. Mice were subjected to treatment with EEAJT and standard drug f

Style APA, Harvard, Vancouver, ISO itp.

12

Belmonte, Yolanda, Oriol de Fabregues, Marta Marti, and Christian Domingo. "Pleuropulmonary Toxicity of Another Anti-Parkinson`s Drug: Cabergoline." Open Respiratory Medicine Journal 3, no. 1 (2009): 90–93. http://dx.doi.org/10.2174/1874306400903010090.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Wahner, A. D., J. M. Bronstein, Y. M. Bordelon, and B. Ritz. "Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease." Neurology 69, no. 19 (2007): 1836–42. http://dx.doi.org/10.1212/01.wnl.0000279519.99344.ad.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Yehuda, Shlomo. "Possible anti-Parkinson properties of N-(α-linolenoyl) tyrosine". Pharmacology Biochemistry and Behavior 72, № 1-2 (2002): 7–11. http://dx.doi.org/10.1016/s0091-3057(01)00646-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Vestergaard, Peter, Lars Rejnmark, and Leif Mosekilde. "Fracture Risk Associated with Parkinsonism and Anti-Parkinson Drugs." Calcified Tissue International 81, no. 3 (2007): 153–61. http://dx.doi.org/10.1007/s00223-007-9065-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

SIMON, K., V. HARMAT, Z. TOEROEK, Z. BOECSKEI, and I. HERMECZ. "ChemInform Abstract: Isostructural Metabolites of Two Anti-Parkinson Drugs." ChemInform 29, no. 44 (2010): no. http://dx.doi.org/10.1002/chin.199844033.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Hollingworth, Samantha A., Amanda Rush, Wayne D. Hall, and Mervyn J. Eadie. "Utilization of anti-Parkinson drugs in Australia: 1995-2009." Pharmacoepidemiology and Drug Safety 20, no. 5 (2011): 450–56. http://dx.doi.org/10.1002/pds.2114.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Youdim, Moussa B. H., and Marta Weinstock. "Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline." Mechanisms of Ageing and Development 123, no. 8 (2002): 1081–86. http://dx.doi.org/10.1016/s0047-6374(01)00391-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Raj, Chanchal N., A. Balasubramaniam, and Sayyed Nadeem. "Effect of various extracts of Tabernaemontana divaricata on haloperidol induced catalepsy in rats." International Current Pharmaceutical Journal 3, no. 3 (2014): 240–42. http://dx.doi.org/10.3329/icpj.v3i3.17891.

Pełny tekst źródła

Streszczenie:

Parkinsons disease (PD) is one of the neurodegenerative diseases with selective loss of dopamine neurons of the substantia nigra pars compacta. In the present study, anti-cataleptic activity of Tabernaemontana divaricata leaves extracts viz. aqueous and ethanolic at different doses (50, 100 and 150 mg/kg i.p.) were studied using haloperidol (1 mg/kg, i.p.) induced catalepsy in rats which is a useful animal model for screening drugs for Parkinsons disease. Both the extracts were found to reduce catalepsy significantly (P<0.001) as compared to the haloperidol treated rats showing greater ef

Style APA, Harvard, Vancouver, ISO itp.

20

Khan, Asif, Fizan Ullah, Huda Mohammed Alkreathy, Mushtaq Ahmed, and Rahmat Ali Khan. "Phytochemical screening, antioxidant and anti-Parkinson activities of Berula erecta: A novel medicinal plant." PLOS ONE 19, no. 11 (2024): e0305751. http://dx.doi.org/10.1371/journal.pone.0305751.

Pełny tekst źródła

Streszczenie:

Berula erecta L. is traditionally used for the treatment of various human ailments. The present project was arranged to study the antioxidant and anti-Parkinson efficacy of B. erecta extracts against rotenone-induced Parkinson diseases in rats. Fine powder of the plant was extracted with methanol and then fractionated through various solvents with increasing order of polarity. Phytochemical screenings were done using standard protocols and High-performance liquid chromatography (HPLC) while in-vitro antioxidant activities of plant fractions were evaluated using different free radicals. In-vivo

Style APA, Harvard, Vancouver, ISO itp.

21

Gupta, Meenakshi, Kamal Kant, Ruchika Sharma та Anoop Kumar. "Evaluation of In Silico Anti-parkinson Potential of β-asarone". Central Nervous System Agents in Medicinal Chemistry 18, № 2 (2018): 128–35. http://dx.doi.org/10.2174/1871524918666180416153742.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

McGeer, Edith G., and Patrick L. McGeer. "The Role of Anti-Inflammatory Agents in Parkinson???s Disease." CNS Drugs 21, no. 10 (2007): 789–97. http://dx.doi.org/10.2165/00023210-200721100-00001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Muthukrishnan, Murugan, Anjaneyulu Reddi, Mohammad Mujahid, and Murugesan Sasikumar. "A New Enantioselective Synthesis of the Anti-Parkinson Agent Safinamide." Synthesis 46, no. 13 (2014): 1751–56. http://dx.doi.org/10.1055/s-0033-1341104.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Bornebroek, Marjolijn, Lonneke M. L. de Lau, Mendel D. M. Haag, et al. "Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease." Neuroepidemiology 28, no. 4 (2007): 193–96. http://dx.doi.org/10.1159/000108110.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Horstink, Martin W. I. M., Charlotte Haaxma, and Bastiaan R. Bloem. "About the Anti-Parkinson Equivalency of Levodopa and Dopamine Agonists." Clinical Neuropharmacology 30, no. 1 (2007): 60–62. http://dx.doi.org/10.1097/01.wnf.0000240952.26444.04.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Ren, Li, Jie Yi, Jing Yang, Peng Li, Xueyan Cheng, and Peixian Mao. "Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease." Medicine 97, no. 37 (2018): e12172. http://dx.doi.org/10.1097/md.0000000000012172.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Ramachandran, Sharavan, and Sanjay K. Srivastava. "Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy." Molecular Therapy - Oncolytics 19 (December 2020): 19–32. http://dx.doi.org/10.1016/j.omto.2020.08.019.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Koller, W. C., J. Z. Fields, J. H. Gordon, and M. J. Perlow. "Evaluation of ciladopa hydrochloride as a potential anti-parkinson drug." Neuropharmacology 25, no. 9 (1986): 973–79. http://dx.doi.org/10.1016/0028-3908(86)90190-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Tüfekçioğlu, Zeynep, Haşmet Hanağası, Gül Yalçın Çakmaklı, et al. "Use of anti-Parkinson medication during pregnancy: a case series." Journal of Neurology 265, no. 8 (2018): 1922–29. http://dx.doi.org/10.1007/s00415-018-8937-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Caccia, C., R. Maj, M. Calabresi, et al. "Safinamide: From molecular targets to a new anti-Parkinson drug." Neurology 67, Issue 7, Supplement 2 (2006): S18—S23. http://dx.doi.org/10.1212/wnl.67.7_suppl_2.s18.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Soni, Som D., and D. A. W. Johnson. "Anticholinergic Anti-Parkinson Medication for Neuroleptic-induced Extrapyramidal Side Effects." British Journal of Psychiatry 149, no. 3 (1986): 386. http://dx.doi.org/10.1192/bjp.149.3.386a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Hernán, Miguel A., Giancarlo Logroscino, and Luis A. García Rodríguez. "Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease." Neurology 66, no. 7 (2006): 1097–99. http://dx.doi.org/10.1212/01.wnl.0000204446.82823.28.

Pełny tekst źródła

Streszczenie:

Animal and epidemiologic studies suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the incidence of Parkinson disease (PD). The authors studied 1,258 PD cases and 6,638 controls from the General Practice Research Database. The odds ratios (95% CI) for ever vs never use were 0.93 (0.80 to 1.08) for nonaspirin NSAIDs, 1.29 (1.05 to 1.58) for aspirin, and 1.16 (1.00 to 1.35) for acetaminophen. Nonaspirin NSAID use was associated with a higher risk in women and a lower risk in men.

Style APA, Harvard, Vancouver, ISO itp.

33

Malaiwong, Nawaphat, Pawanrat Chalorak, Prapaporn Jattujan, et al. "Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota." Biomedicine & Pharmacotherapy 109 (January 2019): 1967–77. http://dx.doi.org/10.1016/j.biopha.2018.11.063.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Chen, Honglei, Shumin M. Zhang, Miguel A. Hernán, et al. "Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease." Archives of Neurology 60, no. 8 (2003): 1059. http://dx.doi.org/10.1001/archneur.60.8.1059.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Ruby, S., and B. Jaykar. "Isolation of Pyran Composition and Anti-Parkinson’s Activity of euphorbia Cyathophora." Asian Journal of Pharmaceutical Research and Development 7, no. 3 (2019): 67–74. http://dx.doi.org/10.22270/ajprd.v7i3.517.

Pełny tekst źródła

Streszczenie:

Aim of the study: The aim of this research was to investigate the phytochemical profile, isolate the phytoconsitutuents, Characterised and evaluation of Anti Parkinson activity of ethanolic extract of Indian Medicinal plant of E.cyathophora Materials and methods: Qualitative phytochemical analysis for their phyto constituents. Ethanol was used to extract the crude bio active compound from whole E. Cyathophora plant. Phenolic derivative were isolated from the ethanolic extract of E. cyathophora by using suitable solvent system and characterised by IR, NMR, MASS spectrophotometric method. The to

Style APA, Harvard, Vancouver, ISO itp.

36

Helena, M. van Oers. "Correlates of psychiatric and psychological distress in patients with Parkinson's disease." Journal of Physical Health and Sports Medicine 2, no. 2 (2019): 50–60. https://doi.org/10.36811/jphsm.2019.110010.

Pełny tekst źródła

Streszczenie:

Parkinson’s disease is the second most commonly diagnosed neurodegenerative disorder worldwide and the physical manifestations of the disease are well documented in the literature. However, in excess of 60% of patients with the disease report having one or more psychiatric symptoms which worsen as the disease progresses. These symptoms arise differentially from the same pathology which underlies the disease or from the treatment with dopaminergic drugs. Psychiatric and psychological difficulties tend to be under-recognised and undertreated yet cause great disability, significantly impact

Style APA, Harvard, Vancouver, ISO itp.

37

Dr., K. Chandra Sekhar M. S.* K. Sravana Lakshmi. "A Review Article on Recent Advances in The Pharmacological Diversification of Imidazole Derivatives." International Journal of Pharmaceutical Sciences 3, no. 4 (2025): 1581–99. https://doi.org/10.5281/zenodo.15205082.

Pełny tekst źródła

Streszczenie:

Furan a five membered aromatic heterocyclic ring system with O present at 1st position made up of 4C and4 H atoms furan ring is a part of many natural productslikeFurano flavonoid, furanocoumarins, etc... Furan nucleus show several biological applications and also shows strong affinity for a range of receptorsfuran and its derivatives are used in synthesis of many novel drugs. The antibacterial, antifungal, antiviral, anti-inflammatory, analgesic, anti-depressant, anti-anxiolytic, anti-Parkinson, anti-glaucoma, muscle-relaxant, anti-hypertensive, diuretics, anti-ulcer, anti-aging, anti-cancer,

Style APA, Harvard, Vancouver, ISO itp.

38

B, K. Supriya, Prem Kumar N, Gurung Pravash, Bhujel Barsha, Gupta Dikcha, and Deekshitha A. "Antiparkinsonian Activity of Hydroalcoholic Extract of Operculina turpethum Roots in Reserpine Induced Parkinsonism in Wistar Rats." Indian Journal of Science and Technology 16, no. 48 (2023): 4710–20. https://doi.org/10.17485/IJST/v16i48.3023.

Pełny tekst źródła

Streszczenie:

Abstract <strong>Objective:</strong> The aim of this study was to examine the effect of Operculina turpethum (Linn.) root extract in attenuating reserpine induced Parkinson’s disease to quench the free radicals produced as a result of the increased oxidative stress in Parkinson disease. <strong>Methods:</strong> Parkinson’s disease is induced by administration of reserpine (0.1 mg/kg/day, i.p.) in albino rats for 21 days. Simultaneously the rats were pretreated with two doses of hydroalcoholic extract of Operculina turpethum (200mg/kg and 400mg/kg p.o.) daily once fo

Style APA, Harvard, Vancouver, ISO itp.

39

Gluck, M. R., L. A. Santana, H. Granson, and M. D. Yahr. "Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson?s activity." Journal of Neural Transmission 111, no. 6 (2004): 713–24. http://dx.doi.org/10.1007/s00702-004-0107-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Cataldi, Samuela, Michela Codini, Stéphane Hunot, et al. "e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease." Mediators of Inflammation 2016 (2016): 1–7. http://dx.doi.org/10.1155/2016/3937057.

Pełny tekst źródła

Streszczenie:

Today a large number of studies are focused on clarifying the complexity and diversity of the pathogenetic mechanisms inducing Parkinson disease. We used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin that induces Parkinson disease, to evaluate the change of midbrain structure and the behavior of the anti-inflammatory factor e-cadherin, interleukin-6, tyrosine hydroxylase, phosphatase and tensin homolog, and caveolin-1. The results showed a strong expression of e-cadherin, variation of length and thickness of the heavy neurofilaments, increase of interleukin-6, and reduction

Style APA, Harvard, Vancouver, ISO itp.

41

HINCH, ROBERT. "MODELING OF WOLFF–PARKINSON–WHITE SYNDROME." International Journal of Bifurcation and Chaos 13, no. 12 (2003): 3827–34. http://dx.doi.org/10.1142/s0218127403008922.

Pełny tekst źródła

Streszczenie:

Wolff–Parkinson–White syndrome is a disease where an arrhythmia is caused by the ventricles being electrically excited by an additional accessory pathway that links the atria to the ventricles. The spread of the activation wave from this pathway to the ventricles is modeled using a simplified model of Hodgkin–Huxley sodium channel kinetics, in a two ion-channel model. The model is investigated both analytically (using an asymptotic analysis) and numerically, and both methods are shown to give the same result. It is found that for a given width of the accessory pathway, there is a critical sodi

Style APA, Harvard, Vancouver, ISO itp.

42

Sahoo, Satyabrata, Asutosh Pal, Syed Mohammad Naser, et al. "Antiparkinson’s drug-effects on quality of life and safety among parkinson disease patients- A prospective observational study in a tertiary care hospital of West-Bengal." Panacea Journal of Medical Sciences 14, no. 2 (2024): 409–14. http://dx.doi.org/10.18231/j.pjms.2024.073.

Pełny tekst źródła

Streszczenie:

Parkinson’s disease (PD) is the second most frequent neurodegenerative disease, affecting 1% of the population aged&#62;60 years due to striatal dopamine deficiency. Dopamine replacement with oral levodopa is the gold standard of symptomatic therapy. Longterm therapy with dopamine agonists might lead to decreased benefit and referred to as ‘end of dose deterioration’ or ‘wearing-off. This leads to decrease quality of life of such patients. There might be safety issues due to longterm use of these drugs. There are few studies conducted in India regarding quality of life studies and safety o

Style APA, Harvard, Vancouver, ISO itp.

43

Omori, Alvaro T., and Vanessa M. Higa. "A Two Hour Synthesis of the Anti-Parkinson Drug Safinamide Methanesulfonate." Synlett 32, no. 14 (2021): 1433–36. http://dx.doi.org/10.1055/a-1534-0343.

Pełny tekst źródła

Streszczenie:

AbstractThe critical moment of the COVID-19 outbreak requires a real-time supply of therapeutic agents. Thus, time economy in the synthesis of biologically active compounds has become increasingly decisive. In this work, we developed a two hour synthesis of the anti-Parkinson drug safinamide methanesulfonate in four steps with a 64% overall yield. Microwave irradiation was used in the first three steps in a one-pot fashion. In fact, the protocol can provide safinamide free base in one hour without a chromatographic purification step. Also, green solvents such as methanol and ethyl acetate are

Style APA, Harvard, Vancouver, ISO itp.

44

Chu, Guo-Guo, Jing Wang, Guang-Yuan Han, et al. "Hydroxyfasudil ameliorates Parkinson’ s disease possibly through anti-inflammation and neuroprotection." Journal of the Neurological Sciences 429 (October 2021): 119483. http://dx.doi.org/10.1016/j.jns.2021.119483.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Bhangale, Jitendra O., and Sanjeev R. Acharya. "Anti-Parkinson Activity of Petroleum Ether Extract ofFicus religiosa(L.) Leaves." Advances in Pharmacological Sciences 2016 (2016): 1–9. http://dx.doi.org/10.1155/2016/9436106.

Pełny tekst źródła

Streszczenie:

In the present study, we evaluated anti-Parkinson’s activity of petroleum ether extract ofFicus religiosa(PEFRE) leaves in haloperidol and 6 hydroxydopamine (6-OHDA) induced experimental animal models. In this study, effects ofFicus religiosa(100, 200, and 400 mg/kg, p.o.) were studied using in vivo behavioral parameters like catalepsy, muscle rigidity, and locomotor activity and its effects on neurochemical parameters (MDA, CAT, SOD, and GSH) in rats. The experiment was designed by giving haloperidol to induce catalepsy and 6-OHDA to induce Parkinson’s disease-like symptoms. The increased cat

Style APA, Harvard, Vancouver, ISO itp.

46

Govoni, V., E. Granieri, M. R. Tola, et al. "Prevalence of anti-parkinson drugs’ use in Ferrara, Northern Italy, 1988." Acta Neurologica Scandinavica 89, no. 6 (2009): 433–38. http://dx.doi.org/10.1111/j.1600-0404.1994.tb02662.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Brandt-Christensen, M., A. G. Lopez, F. M. Nilsson, P. K. Andersen, and L. V. Kessing. "Depressive disorders and anti-parkinson drug treatment: a case register study." Acta Psychiatrica Scandinavica 115, no. 6 (2007): 466–72. http://dx.doi.org/10.1111/j.1600-0447.2006.00975.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Schroeder, C., H. Heider, B. Hegenscheid, M. Schöffel, V. I. Bubovich, and H. A. Rosenthal. "The anticholinergic anti-parkinson drug norakinR selectively inhibits influenza virus replication." Antiviral Research 5 (January 1985): 95–99. http://dx.doi.org/10.1016/s0166-3542(85)80014-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Kowa, H., F. Kanda, and T. Toda. "SAFETY AND EFFICIENCY OF ANTI-PARKINSON DRUGS FOR DLB/PDD PATIENTS." Innovation in Aging 1, suppl_1 (2017): 169. http://dx.doi.org/10.1093/geroni/igx004.658.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Gagne, J. J., and M. C. Power. "Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis." Neurology 74, no. 12 (2010): 995–1002. http://dx.doi.org/10.1212/wnl.0b013e3181d5a4a3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!